Table of Contents Author Guidelines Submit a Manuscript
The Scientific World Journal
Volume 2014, Article ID 424513, 12 pages
http://dx.doi.org/10.1155/2014/424513
Review Article

Solid Tumor-Targeting Theranostic Polymer Nanoparticle in Nuclear Medicinal Fields

1Biomedical Imaging Research Center (BIRC), University of Fukui, Fukui 910-1193, Japan
2Research and Education Program for Life Science, University of Fukui, Fukui 910-1193, Japan
3Department of Material Chemistry, Graduate School of Engineering, Kyoto University, Kyoto 615-8510, Japan

Received 27 June 2014; Revised 8 August 2014; Accepted 11 August 2014; Published 14 October 2014

Academic Editor: Masashi Ueda

Copyright © 2014 Akira Makino and Shunsaku Kimura. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. Hao, R. J. Xing, Z. C. Xu, Y. L. Hou, S. Goo, and S. H. Sun, “Synthesis, functionalization, and biomedical applications of multifunctional magnetic nanoparticles,” Advanced Materials, vol. 22, no. 25, pp. 2729–2742, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. P. Horcajada, R. Gref, T. Baati et al., “Metal-organic frameworks in biomedicine,” Chemical Reviews, vol. 112, no. 2, pp. 1232–1268, 2012. View at Publisher · View at Google Scholar · View at Scopus
  3. D. Peer, J. M. Karp, S. Hong, O. C. Farokhzad, R. Margalit, and R. Langer, “Nanocarriers as an emerging platform for cancer therapy,” Nature Nanotechnology, vol. 2, no. 12, pp. 751–760, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. M. Ferrari, “Cancer nanotechnology: opportunities and challenges,” Nature Reviews Cancer, vol. 5, no. 3, pp. 161–171, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. R. K. Jain and T. Stylianopoulos, “Delivering nanomedicine to solid tumors,” Nature Reviews Clinical Oncology, vol. 7, no. 11, pp. 653–664, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. Z. Jiao, X. Wang, and Z. Chen, “Advance of amphiphilic block copolymeric micelles as drug delivery,” Asian Journal of Chemistry, vol. 25, no. 4, pp. 1765–1769, 2013. View at Google Scholar · View at Scopus
  7. M. Elsabahy and K. L. Wooley, “Design of polymeric nanoparticles for biomedical delivery applications,” Chemical Society Reviews, vol. 41, no. 7, pp. 2545–2561, 2012. View at Publisher · View at Google Scholar · View at Scopus
  8. Z. Ge and S. Liu, “Functional block copolymer assemblies responsive to tumor and intracellular microenvironments for site-specific drug delivery and enhanced imaging performance,” Chemical Society Reviews, vol. 42, no. 17, pp. 7289–7325, 2013. View at Publisher · View at Google Scholar · View at Scopus
  9. S. Ganta, H. Devalapally, A. Shahiwala, and M. Amiji, “A review of stimuli-responsive nanocarriers for drug and gene delivery,” Journal of Controlled Release, vol. 126, no. 3, pp. 187–204, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. J. H. Park, S. Lee, J.-H. Kim, K. Park, K. Kim, and I. C. Kwon, “Polymeric nanomedicine for cancer therapy,” Progress in Polymer Science, vol. 33, no. 1, pp. 113–137, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. J. Fang, H. Nakamura, and H. Maeda, “The EPR effect: unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect,” Advanced Drug Delivery Reviews, vol. 63, no. 3, pp. 136–151, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. A. K. Iyer, G. Khaled, J. Fang, and H. Maeda, “Exploiting the enhanced permeability and retention effect for tumor targeting,” Drug Discovery Today, vol. 11, no. 17-18, pp. 812–818, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. H. Maeda, J. Wu, T. Sawa, Y. Matsumura, and K. Hori, “Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review,” Journal of Controlled Release, vol. 65, no. 1-2, pp. 271–284, 2000. View at Publisher · View at Google Scholar · View at Scopus
  14. L. Brannon-Peppas and J. O. Blanchette, “Nanoparticle and targeted systems for cancer therapy,” Advanced Drug Delivery Reviews, vol. 64, pp. 206–212, 2012. View at Publisher · View at Google Scholar · View at Scopus
  15. S. P. Egusquiaguirre, M. Igartua, R. M. Hernández, and J. L. Pedraz, “Nanoparticle delivery systems for cancer therapy: advances in clinical and preclinical research,” Clinical and Translational Oncology, vol. 14, no. 2, pp. 83–93, 2012. View at Publisher · View at Google Scholar · View at Scopus
  16. H. Tanisaka, S. Kizaka-Kondoh, A. Makino, S. Tanaka, M. Hiraoka, and S. Kimura, “Near-infrared fluorescent labeled peptosome for application to cancer imaging,” Bioconjugate Chemistry, vol. 19, no. 1, pp. 109–117, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. Y. Chen and X. Li, “Near-infrared fluorescent nanocapsules with reversible response to thermal/PH modulation for optical imaging,” Biomacromolecules, vol. 12, no. 12, pp. 4367–4372, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. A. Makino, S. Kizaka-Kondoh, R. Yamahara et al., “Near-infrared fluorescence tumor imaging using nanocarrier composed of poly(l-lactic acid)-block-poly(sarcosine) amphiphilic polydepsipeptide,” Biomaterials, vol. 30, no. 28, pp. 5156–5160, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. R. Weissleder, “A clearer vision for in vivo imaging,” Nature Biotechnology, vol. 19, no. 4, pp. 316–317, 2001. View at Publisher · View at Google Scholar · View at Scopus
  20. D. L. Bailey and K. P. Willowson, “Quantitative SPECT/CT: SPECT joins PET as a quantitative imaging modality,” European Journal of Nuclear Medicine and Molecular Imaging, vol. 41, no. 1, pp. 17–25, 2013. View at Publisher · View at Google Scholar · View at Scopus
  21. Y. Li, S. M. A. Rizvi, J. M. Blair et al., “Antigenic expression of human metastatic prostate cancer cell lines for in vitro multiple-targeted α-therapy with 213Bi-conjugates,” International Journal of Radiation Oncology Biology Physics, vol. 60, no. 3, pp. 896–908, 2004. View at Publisher · View at Google Scholar · View at Scopus
  22. B. Cornelissen, S. Darbar, R. Hernandez et al., “ErbB-2 blockade and prenyltransferase inhibition alter epidermal growth factor and epidermal growth factor receptor trafficking and enhance 111In-DTPA-hEGF auger electron radiation therapy,” Journal of Nuclear Medicine, vol. 52, no. 5, pp. 776–783, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. D. L. Costantini, C. Chan, Z. L. Cai, K. A. Vallis, and R. M. Reilly, “111In-labeled trastuzumab (Herceptin) modified with nuclear localization sequences (NLS): an auger electron-emitting radiotherapeutic agent for HER2/neu-amplified breast cancer,” The Journal of Nuclear Medicine, vol. 48, no. 8, pp. 1357–1368, 2007. View at Publisher · View at Google Scholar · View at Scopus
  24. B. Cambien, P. R. Franken, A. Lamit et al., “(TcO4-)-Tc-99m-, auger-mediated thyroid stunning: dosimetric requirements and associated molecular events,” PLoS ONE, vol. 9, no. 3, Article ID e92729, 2014. View at Publisher · View at Google Scholar · View at Scopus
  25. W. D. Bloomer and S. J. Adelstein, “5-125I-iododeoxyuridine as prototype for radionuclide therapy with Auger emitters,” Nature, vol. 265, no. 5595, pp. 620–621, 1977. View at Publisher · View at Google Scholar · View at Scopus
  26. R. Rossin, D. P. J. Pan, K. Qi et al., “64Cu-labeled folate-conjugated shell cross-linked nanoparticles for tumor imaging and radiotherapy: synthesis, radiolabeling, and biologic evaluation,” Journal of Nuclear Medicine, vol. 46, no. 7, pp. 1210–1218, 2005. View at Google Scholar · View at Scopus
  27. K. Qi, Q. Ma, E. E. Remsen, C. G. Clark Jr., and K. L. Wooley, “Determination of the bioavailability of biotin conjugated onto shell cross-linked (SCK) nanoparticles,” Journal of the American Chemical Society, vol. 126, no. 21, pp. 6599–6607, 2004. View at Publisher · View at Google Scholar · View at Scopus
  28. J. Sudimack and R. J. Lee, “Targeted drug delivery via the folate receptor,” Advanced Drug Delivery Reviews, vol. 41, no. 2, pp. 147–162, 2000. View at Publisher · View at Google Scholar · View at Scopus
  29. E. D. Pressly, R. Rossin, A. Hagooly et al., “Structural effects on the biodistribution and positron emission tomograpgy (PET) imaging of well-defined 64Cu-labeled nanoparticles comprised of amphiphilic block graft copolymers,” Biomacromolecules, vol. 8, no. 10, pp. 3126–3134, 2007. View at Publisher · View at Google Scholar · View at Scopus
  30. M. Allmeroth, D. Moderegger, D. Gündel et al., “PEGylation of HPMA-based block copolymers enhances tumor accumulation in vivo: a quantitative study using radiolabeling and positron emission tomography,” Journal of Controlled Release, vol. 172, no. 1, pp. 77–85, 2013. View at Publisher · View at Google Scholar · View at Scopus
  31. M. Allmeroth, D. Moderegger, D. Gündel et al., “HPMA-LMA copolymer drug carriers in oncology: an in vivo PET study to assess the tumor line-specific polymer uptake and body distribution,” Biomacromolecules, vol. 14, no. 9, pp. 3091–3101, 2013. View at Publisher · View at Google Scholar · View at Scopus
  32. Z. Yang, S. Zheng, W. J. Harrison et al., “Long-circulating near-infrared fluorescence core-cross-linked polymeric micelles: synthesis, characterization, and dual nuclear/optical imaging,” Biomacromolecules, vol. 8, no. 11, pp. 3422–3428, 2007. View at Publisher · View at Google Scholar · View at Scopus
  33. R. Zhang, C. Xiong, M. Huang et al., “Peptide-conjugated polymeric micellar nanoparticles for Dual SPECT and optical imaging of EphB4 receptors in prostate cancer xenografts,” Biomaterials, vol. 32, no. 25, pp. 5872–5879, 2011. View at Publisher · View at Google Scholar · View at Scopus
  34. Y. Hong, H. Zhu, J. Hu et al., “Synthesis and radiolabeling of 111In-core-cross linked polymeric micelle-octreotide for near-infrared fluoroscopy and single photon emission computed tomography imaging,” Bioorganic and Medicinal Chemistry Letters, vol. 24, no. 12, pp. 2781–2785, 2014. View at Publisher · View at Google Scholar · View at Scopus
  35. R. Zhang, W. Lu, X. Wen et al., “Annexin A5-conjugated polymeric micelles for dual SPECT and optical detection of apoptosis,” Journal of Nuclear Medicine, vol. 52, no. 6, pp. 958–964, 2011. View at Publisher · View at Google Scholar · View at Scopus
  36. A. I. Jensen, T. Binderup, P. Kumar Ek, A. Kjær, P. H. Rasmussen, and T. L. Andresen, “Positron emission tomography based analysis of long-circulating cross-linked triblock polymeric micelles in a U87MG mouse xenograft model and comparison of DOTA and CB-TE2A as chelators of copper-64,” Biomacromolecules, vol. 15, no. 5, pp. 1625–1633, 2014. View at Publisher · View at Google Scholar · View at Scopus
  37. M. Okada, “Chemical syntheses of biodegradable polymers,” Progress in Polymer Science, vol. 27, no. 1, pp. 87–133, 2002. View at Publisher · View at Google Scholar · View at Scopus
  38. B. Hoang, H. Lee, R. M. Reilly, and C. Allen, “Noninvasive monitoring of the fate of111in-labeled block copolymer micelles by high resolution and high sensitivity microSPECT/CT imaging,” Molecular Pharmaceutics, vol. 6, no. 2, pp. 581–592, 2009. View at Publisher · View at Google Scholar · View at Scopus
  39. H. Lee, B. Hoang, H. Fonge, R. M. Reilly, and C. Allen, “In vivo distribution of polymeric nanoparticles at the whole-body, tumor, and cellular levels,” Pharmaceutical Research, vol. 27, no. 11, pp. 2343–2355, 2010. View at Publisher · View at Google Scholar · View at Scopus
  40. R. M. Reilly, R. Kiarash, R. G. Cameron et al., “111In-labeled EGF is selectively radiotoxic to human breast cancer cells overexpressing EGFR,” Journal of Nuclear Medicine, vol. 41, no. 3, pp. 429–438, 2000. View at Google Scholar · View at Scopus
  41. H. Fonge, H. Lee, R. M. Reilly, and C. Allen, “Multifunctional block copolymer micelles for the delivery of 111in to EGFR-positive breast cancer cells for targeted Auger electron radiotherapy,” Molecular Pharmaceutics, vol. 7, no. 1, pp. 177–186, 2010. View at Publisher · View at Google Scholar · View at Scopus
  42. B. Hoang, R. M. Reilly, and C. Allen, “Block copolymer micelles target auger electron radiotherapy to the nucleus of HER2-positive breast cancer cells,” Biomacromolecules, vol. 13, no. 2, pp. 455–465, 2012. View at Publisher · View at Google Scholar · View at Scopus
  43. B. Hoang, S. N. Ekdawi, R. M. Reilly, and C. Allen, “Active targeting of block copolymer micelles with trastuzumab fab fragments and nuclear localization signal leads to increased tumor uptake and nuclear localization in HER2-overexpressing xenografts,” Molecular Pharmaceutics, vol. 10, no. 11, pp. 4229–4241, 2013. View at Publisher · View at Google Scholar · View at Scopus
  44. C.-C. Cheng, C.-F. Huang, A.-S. Ho et al., “Novel targeted nuclear imaging agent for gastric cancer diagnosis: glucose-regulated protein 78 binding peptide-guided 111In-labeled polymeric micelles,” International Journal of Nanomedicine, vol. 8, pp. 1385–1391, 2013. View at Publisher · View at Google Scholar · View at Scopus
  45. C.-L. Peng, Y.-H. Shih, P.-C. Lee, T. M.-H. Hsieh, T.-Y. Luo, and M.-J. Shieh, “Multimodal image-guided photothermal therapy mediated by188Re-labeled micelles containing a cyanine-type photosensitizer,” ACS Nano, vol. 5, no. 7, pp. 5594–5607, 2011. View at Publisher · View at Google Scholar · View at Scopus
  46. C.-L. Peng, Y.-H. Shih, K.-S. Liang et al., “Development of in situ forming thermosensitive hydrogel for radiotherapy combined with chemotherapy in a mouse model of hepatocellular carcinoma,” Molecular Pharmaceutics, vol. 10, no. 5, pp. 1854–1864, 2013. View at Publisher · View at Google Scholar · View at Scopus
  47. D. H. Yu, Q. Lu, J. Xie, C. Fang, and H. Z. Chen, “Peptide-conjugated biodegradable nanoparticles as a carrier to target paclitaxel to tumor neovasculature,” Biomaterials, vol. 31, no. 8, pp. 2278–2292, 2010. View at Publisher · View at Google Scholar · View at Scopus
  48. S. Sumitani, M. Oishi, T. Yaguchi et al., “Pharmacokinetics of core-polymerized, boron-conjugated micelles designed for boron neutron capture therapy for cancer,” Biomaterials, vol. 33, no. 13, pp. 3568–3577, 2012. View at Publisher · View at Google Scholar · View at Scopus
  49. S. Sumitani and Y. Nagasaki, “Boron neutron capture therapy assisted by boron-conjugated nanoparticles,” Polymer Journal, vol. 44, no. 6, pp. 522–530, 2012. View at Publisher · View at Google Scholar · View at Scopus
  50. A. Makino, E. Hara, I. Hara et al., “Control of in vivo blood clearance time of polymeric micelle by stereochemistry of amphiphilic polydepsipeptides,” Journal of Controlled Release, vol. 161, no. 3, pp. 821–825, 2012. View at Publisher · View at Google Scholar · View at Scopus
  51. F. Yamamoto, R. Yamahara, A. Makino et al., “Radiosynthesis and initial evaluation of 18F labeled nanocarrier composed of poly(L-lactic acid)-block-poly(sarcosine) amphiphilic polydepsipeptide,” Nuclear Medicine and Biology, vol. 40, no. 3, pp. 387–394, 2013. View at Publisher · View at Google Scholar · View at Scopus
  52. E. Hara, A. Makino, K. Kurihara et al., “Radionuclide therapy using nanoparticle of131I-Lactosome in combination with percutaneous ethanol injection therapy,” Journal of Nanoparticle Research, vol. 15, Article ID 2131, 2013. View at Publisher · View at Google Scholar · View at Scopus
  53. E. Hara, A. Makino, K. Kurihara, F. Yamamoto, E. Ozeki, and S. Kimura, “Pharmacokinetic change of nanoparticulate formulation “Lactosome” on multiple administrations,” International Immunopharmacology, vol. 14, no. 3, pp. 261–266, 2012. View at Publisher · View at Google Scholar · View at Scopus
  54. T. Ishida and H. Kiwada, “Accelerated blood clearance (ABC) phenomenon upon repeated injection of PEGylated liposomes,” International Journal of Pharmaceutics, vol. 354, no. 1-2, pp. 56–62, 2008. View at Publisher · View at Google Scholar · View at Scopus
  55. A. S. Abu Lila, H. Kiwada, and T. Ishida, “The accelerated blood clearance (ABC) phenomenon: clinical challenge and approaches to manage,” Journal of Controlled Release, vol. 172, no. 1, pp. 38–47, 2013. View at Publisher · View at Google Scholar · View at Scopus
  56. E. Hara, A. Makino, K. Kurihara et al., “Evasion from accelerated blood clearance of nanocarrier named as “lactosome” induced by excessive administration of Lactosome,” Biochimica et Biophysica Acta—General Subjects, vol. 1830, no. 8, pp. 4046–4052, 2013. View at Publisher · View at Google Scholar · View at Scopus
  57. E. Hara, M. Ueda, A. Makino, I. Hara, E. Ozeki, and S. Kimura, “Factors influences in vivo disposition of polymeric micelles on multiple administrations,” ACS Medicinal Chemistry Letters, vol. 5, no. 8, pp. 873–877, 2014. View at Publisher · View at Google Scholar
  58. P.-L. Lu, Y.-C. Chen, T.-W. Ou et al., “Multifunctional hollow nanoparticles based on graft-diblock copolymers for doxorubicin delivery,” Biomaterials, vol. 32, no. 8, pp. 2213–2221, 2011. View at Publisher · View at Google Scholar · View at Scopus
  59. M. G. Wacker, “Nanotherapeutics—product development along the nanomaterial discussion,” Journal of Pharmaceutical Sciences, vol. 103, no. 3, pp. 777–784, 2014. View at Publisher · View at Google Scholar · View at Scopus